Changhai Ding, M.D., Ph.D., of the University of Tasmania, Hobart, Tasmania, Australia, and colleagues randomly assigned 413
patients with
symptomatic knee osteoarthritis and low 25 - hydroxyvitamin D to
receive monthly treatment with oral vitamin D3 (50,000 IU; n = 209) or an identical placebo (n = 204) for 2 years.
In mid 2010, we collated data on all adult Indigenous
patients in the region who where either
symptomatic or in remission and
receiving treatment for a psychotic disorder falling within the following International Classification of Diseases, 10th revision groups: organic - related (F06); substance use - related (F10 — 19); schizophrenia - related (F20 — 22); acute and transient psychoses (F23); and mood disorder - related (F25, F30 — 33).